In myeloid malignancy, a number of recurrent and sporadic rearrangements of 3q26 are associated with transcriptional activation of EVI1 and/or EVI1 chimaeric genes.
1 Recurrent rearrangements include the inv(3)(q21q26) and its variants t(3;3)(q21;q26) and ins(3;3)(q26;q21q26), as well as translocations involving other chromosomes such as the t(3;21)(q26;q22). In general, 3q26 rearrangements are associated with a poor disease prognosis. 2 Given the unfavourable outcome of 3q26 rearrangements, methods for establishing their presence at diagnosis and during treatment or disease progression are highly desirable, particularly when chromosome banding analysis is hampered by low quality or insufficient metaphase cells. To date, however, the wide 3q26 breakpoint region has precluded development of a single fluorescent in situ hybridization (FISH) probe sensitive enough to monitor residual disease. We describe a novel dualcolour FISH probe designed to span the entire 3q26 breakpoint region in a single hybridization, which allowed successful detection and quantification of the level of leukaemic cells in 11 patients with 3q26 rearrangements. Physical mapping data obtained with this probe further support the notion of a degree of rearrangement-specific breakpoint clustering within cytogenetic subgroups of 3q26 abnormality.
The dual-colour EVI1 FISH probe was designed to comprise two differentially labelled DNA contigs flanking the common 3q26 breakpoint region (Figure 1 ). Expected signal patterns from Structure and principle of the EVI1 break-apart fluorescent in situ hybridization (FISH) probe system. The probe is composed of two differentially labelled contigs specific for the 3q26 locus (Kreatech Biotechnologies, Amsterdam, The Netherlands). The most centromeric contig, labelled in green fluorochrome, hybridizes to a region extending 460 kb from the centromeric (3 0 ) end of the EVI1 gene. The second, most telomeric contig, labelled with a red fluorochrome, is specific for a region beginning approximately 500 kb 3 0 of EVI1 and extends 370 kb in a telomeric direction. The distance between the hybridization regions of the two contigs is 530 kb. The breakpoint region associated with 3q26 abnormalities is indicated. The lower portion of the figure shows the principle of the EVI1 break-apart FISH assay with the expected normal and abnormal hybridization patterns. For simplicity, an inv(3)(q21q26) is depicted in the scheme, however, the principles of this approach apply to all 3q26 rearrangements. Letters to the Editor rearrangements at different positions within the known breakpoint region are shown in Figure 1 . Application of the EVI1 probe to metaphase cells without a 3q26 rearrangement produced two red-green fusion signals in metaphase cells (Figure 2a) . To assess the threshold for positivity while performing interphase analysis, 200 nuclei were analysed from 20 control samples without 3q26 rearrangements. Red and green signals were scored as colocalized if they overlapped to form yellow signals, touched each other, or were less than one signal diameter apart. Signals were scored as separate if they were located at more than one signal diameter from each other. 3 The average incidence of each of the three alternative positive signal patterns 1R1G1F, 1G2F and 1R2F (Figure 1 ) in these control samples was 0.5, 0 and 0% respectively. The cutoff value (mean plus 3 s.d.) for the pattern 1R1G1F was set at 3%. Since no cells were observed showing patterns of 1G2F or 1R2F, an arbitrary cutoff of 1% was assigned for these signal configurations.
Application of the EVI1 probe to bone marrow metaphase cells from patients with 3q26 rearrangements produced one of the three possible aberrant signal configurations, consistent with a break within or around the EVI1 locus, in all 11 cases (Table 1; Figures 2b-e). Application of the probe to all six patients with an inv(3)(q21q26) produced either one red, one green and one fusion signal (1R1G1F), or one green and two fusion signals (1G2F), consistent with a breakpoint within EVI1 or not more than 500 kb 5 0 or 3 0 of the gene. In contrast, all five patients with alternative 3q26 rearrangements showed a pattern of one red and two fusion signals consistent with a genomic break between 500 and 870 kb 5 0 (telomeric) of EVI1 within the region of the distal probe contig.
In addition to metaphase analysis, a minimum of 100 interphase nuclei were analysed from each case. Identical hybridization patterns to those seen in metaphase cells were observed in a proportion of nuclei from all 11 patients. The level of interphase cells judged positive by EVI1 FISH in patients 2-6, who demonstrated only 3q26-positive metaphases by G-banding, was markedly lower than 100% (range: 70-91, Table 1 ), suggesting the presence of a normal population of interphase cells. The leukaemic clones in three of these patients (4-6) also The EVI1 break-apart probe pattern observed in patients 1-3 with an inv(3)(q21q26). One intact red-green fusion signal is observed on the normal chromosome 3 homologue, marking the un-rearranged EVI1 locus. In contrast, on the abnormal chromosome 3, a breakpoint centromeric to EVI1 has resulted in a split green signal and a pattern in interphase cells of one green and two fusion signals (1G2F). (c) Signal pattern observed in the remaining patients carrying an inv(3)(q21q26) (4-6) in whom a breakpoint within the 500 kb region immediately 5 0 of EVI1 has resulted in separation of the red and green probe signals on the abnormal chromosome 3 homologue. In interphase cells, this pattern is identifiable as one green signal, one red signal and one fusion (1G1R1F). (d) Signal pattern observed in both patients with a t(3;21)(q26;q22) (patients 7 and 8). A breakpoint over 500 kb distal to the EVI1 gene, within the hybridization region of the red probe component, results in a split red signal from the der(3) and relocation of part of this red signal to the der(21). This produced a pattern in interphase cells of one red and two fusion signals (1R2F). The same interphase signal pattern was also observed in patients 9 and 10, indicating similar breakpoint positions in these patients. (e) EVI1 FISH analysis of patient 10 with an ins(22;3)(q11;q26q21). One intact red-green fusion signal is observed on the normal chromosome 3 homologue, marking the un-rearranged EVI1 locus. In contrast, the second EVI1 hybridization signal reveals relocation and rearrangement of this region, with part of the red 5 0 signal hybridized towards the distal end of the der(22) while the remains of the red 5 0 signal together with the green 3 0 signal are present towards the centromere of this marker. This finding consistent with an inversion of chromosome 3 involving a break distal to EVI1 and a subsequent insertion of 3q material, including the inverted region, into chromosome 22.
Letters to the Editor exhibited other chromosome aberrations amenable to FISH analysis. Hybridization of BCR-ABL or centromere 7 FISH probes to samples from patients 4, 5 and 6 revealed aberrant signal patterns in 92, 60 and 83% of interphases respectively, thus confirming the presence of a substantial proportion of cytogenetically normal cells in the non-dividing fraction. In these and a further three patients in which additional FISH probes were applied (patients 7-9, Table 1), a good correlation was observed between the level of disease cells assessed by EVI1 FISH and that obtained using the alternative probe (mean difference 76.8%; range: 73 to 13%).
Given the poor prognosis of 3q26 rearrangements in myeloid leukaemia, tools for their detection would have valuable clinical applications. However, two recent PCR studies of 3q26-rearranged leukaemias yielded contradictory results, with one report demonstrating a good correlation between 3q26 rearrangements and detectable EVI1 expression, 4 whereas the second reported absence of detectable EVI1 expression in the majority of cases. 5 The large 3q26 breakpoint region also presents a challenge for FISH analysis. Wieser et al. 6 described a dualcolour FISH probe spanning some 2.5 Mb at 3q26, however, the large genomic region represented by the probe resulted in a threshold for positivity of over 10% thus limiting its use for the detection of residual disease. More recently, improved genome mapping data and access to associated resources have led to a narrowing of the common 3q26 breakpoint region. Two recent reports described the application of several pooled BAC clones spanning approximately 1.2 and 1.5 Mb, respectively, which detected most, if not all, rearrangements of 3q26. 4, 7 However, multiple hybridization experiments were required for both these probe sets, rendering them impractical for diagnostic use. The probe described in the present study spans a comparable genomic region to that defined in the latter two reports, but was composed of larger contigs facilitating its application as a single robust assay. This single-assay FISH approach proved to be a rapid and efficient means of detecting 3q26 rearrangement in patients with myeloid malignancies. The probe produced a low incidence of false positivity and would hence be appropriate to confirm or exclude the presence of 3q26 rearrangement at diagnosis and to monitor response to therapy or disease progression.
In agreement with previous reports, we observed a wide variation in genomic breakpoint position at 3q26. The means by which these events mediate long-range effects on the regulation of EVI1 are not well understood, but alteration of chromatin structure represents one potential mechanism. 8 Interestingly, analysis of the precise EVI1 FISH signal configurations in our cohort revealed discrete breakpoint regions for certain cytogenetic subgroups, with inv(3) rearrangements mapping centromeric or just telomeric to EVI1 while other 3q26 rearrangements clustered over 500 kb telomeric to the gene. Previous molecular and FISH mapping studies of 3q26-rearranged leukaemia are, in keeping with our observations, documenting a preponderance of breakpoints centromeric of EVI1 for the inv(3) and telomeric of EVI1 for all other 3q26 rearrangements. 1, 5, 7, 8 However, close scrutiny of published data reveals a degree of overlap between the breakpoint regions of these two cytogenetic subgroups, suggesting that the precise distribution of breakpoints for different types of 3q26 rearrangement may be more complex than observed in the present cohort. Notwithstanding, our findings further stress the importance of a wide genomic region at 3q26 in unravelling the molecular mechanism responsible for deregulated EVI1 expression in myeloid malignancy. Results in patients 4, 6, 7 and 8 were obtained using a BCR-ABL FISH probe; result in patient 5 was obtained with a chromosome 7 centromeric probe; result in patient 9 was obtained using X and Y centromeric probes (Abbott Molecular, Berks, UK).
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment To exploit the diagnostic usefulness of the recently discovered JAK2 V617F mutation, as well as the characteristic bone marrow histopathological features reported in BCR-ABL-negative chronic myeloproliferative disorders, members of the International Working Group for Myelofibrosis Research and Treatment published revised diagnostic criteria for polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis. From a list of candidate criteria and by group consensus, the panel selected two required criteria for the diagnoses of post-PV myelofibrosis and post-ET myelofibrosis (Table 1) . First, a verified diagnosis of pre-existing PV or ET was recommended as crucial for the diagnosis of MF transformation. Due to the Table 1 IWG-MRT recommended criteria for post-PV MF and post-ET MF
Criteria for post-polycythemia vera myelofibrosis
Required criteria: 1 Documentation of a previous diagnosis of polycythemia vera as defined by the WHO criteria 1 2 Bone marrow fibrosis grade 2-3 (on 0-3 scale) 3 or grade 3-4 (on 0-4 scale) 4,a Additional criteria (two are required):
1 Anemia b or sustained loss of requirement of either phlebotomy (in the absence of cytoreductive therapy) or cytoreductive treatment for erythrocytosis 2 A leukoerythroblastic peripheral blood picture 3 Increasing splenomegaly defined as either an increase in palpable splenomegaly of X5 cm (distance of the tip of the spleen from the left costal margin) or the appearance of a newly palpable splenomegaly 4 Development of X1 of three constitutional symptoms: 410% weight loss in 6 months, night sweats, unexplained fever (437.51C) 3 or grade 3-4 (on 0-4 scale) 4,a Additional criteria (two are required):
1 Anemia b and a X2 mg ml À1 decrease from baseline hemoglobin level 2 A leukoerythroblastic peripheral blood picture 3 Increasing splenomegaly defined as either an increase in palpable splenomegaly of X5 cm (distance of the tip of the spleen from the left costal margin) or the appearance of a newly palpable splenomegaly 4 Increased LDH (above reference level) 5 Development of X1 of three constitutional symptoms: 410% weight loss in 6 months, night sweats, unexplained fever (437.51C)
Abbreviations: IWG-MRT, International Working Group for Myelofibrosis Research and Treatment; LDH, lactate dehydrogenase; post-ET MF, post-essential thrombocythemia myelofibrosis; post-PV MF, postpolycythemia vera myelofibrosis. a Grade 2-3 according to the European classification: 3 diffuse, often coarse fiber network with no evidence of collagenization (negative trichrome stain) or diffuse, coarse fiber network with areas of collagenization (positive trichrome stain). Grade 3-4 according to the standard classification:
4 diffuse and dense increase in reticulin with extensive intersections, occasionally with only focal bundles of collagen and/or focal osteosclerosis or diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis. b Below the reference range for appropriate age, sex, gender and altitude considerations.
